First Batch of Coronavirus Medicine Paxlovid Arrives to Serbia

The first batch of the coronavirus medicine Paxlovid has arrived to Serbia. According to the website of the Ministry of Health, Serbia is the first country in continental Europe to get this medicine delivered (in Europe, Great Britain also has it for now), ten days after the European Medicines Agency (EMA) approved the use and sale of this medicine.

The commission of the Ministry of Health presided over by professor Dr Goran Stevanovic, the director of the Clinic for Infectious Diseases, has prepared a distribution list, based on which the medicine will be distributed across the health institutions.

Paxlovid is an antivirus medicine which contains two components, ritonavir and nirmatrelvir, and is meant for oral use. It is indicated for the treatment of a COVID-19 infection, for adults who do not require additional oxygen and who have an increased risk of the disease’s progressing into a more severe form. It is recommended to start taking the medicine within five days of the occurrence of the symptoms, it is explained.

It is added that, at the end of last year, Serbia was one of the first, along with the USA and Great Britain, to sign the agreement with representatives of Pfizer on the procurement of the best medicine against coronavirus, which reduced the risk of hospitalization and severe forms of the disease in patients by up to 89%.

Ministarstvo zdravlja Republike Srbije

EMA

European Medicines Agency

Clinic for Infectious Diseases

Pfizer

Goran Stevanović

coronavirus medicine

coronavirus

covid 19

Paxlovid

antivirus medicine

ritonavir

nirmatrelvir